MedPath

TARO-ETODOLAC

TARO-ETODOLAC

Discontinued
DIN Number

02242915

Drug Class

Human

Market Date

Oct 20, 2000

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02242915
AIG Number0116345002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AB08 ETODOLAC
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ETODOLACActive
Strength: 300 MG
Monograph: ETODOLAC

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.